부산대학교 도서관

Colson AE; Community Resource Initiative, Boston, and Cambridge Health Alliance, Cambridge, Massachusetts (A.E.C.).; Crofoot GE; The Crofoot Research Center, Houston, Texas (G.E.C.).; Ruane PJ; Ruane Clinical Research, Los Angeles, California (P.J.R.).; Ramgopal MN; Midway Immunology & Research Center, Fort Pierce, Florida (M.N.R.).; Dretler AW; Metro Infectious Disease Consultants, Decatur, Georgia (A.W.D.).; Nahass RG; IDCare, Hillsborough, New Jersey (R.G.N.).; Sinclair GI; Prism Health North Texas, Dallas, Texas (G.I.S.).; Berhe M; North Texas Infectious Diseases Consultants, Dallas, Texas (M.B.).; Roberts A; Division of Infectious Diseases, George Washington University School of Medicine and Health Sciences, Washington, DC (A.R.).; Applin S; Community Health Care, Tacoma, Washington (S.A.).; Brinson C; Central Texas Clinical Research, Austin, Texas (C.B.).; Jayaweera D; University of Miami, Miller School of Medicine, Miami, Florida (D.J.).; Workowski KA; Department of Medicine, Division of Infectious Diseases, Emory University, Atlanta, Georgia (K.A.W.).; Shihadeh F; Gilead Sciences, Foster City, California (F.S., S.-Y.L., S.M., H.D.-S., M.S.R., J.M.B.).; Liu SY; Gilead Sciences, Foster City, California (F.S., S.-Y.L., S.M., H.D.-S., M.S.R., J.M.B.).; Klopfer S; Merck & Co., Rahway, New Jersey (S.K., C.L., E.G.R.).; Llamoso C; Merck & Co., Rahway, New Jersey (S.K., C.L., E.G.R.).; Madera S; Gilead Sciences, Foster City, California (F.S., S.-Y.L., S.M., H.D.-S., M.S.R., J.M.B.).; Dvory-Sobol H; Gilead Sciences, Foster City, California (F.S., S.-Y.L., S.M., H.D.-S., M.S.R., J.M.B.).; Rhee MS; Gilead Sciences, Foster City, California (F.S., S.-Y.L., S.M., H.D.-S., M.S.R., J.M.B.).; Rhee EG; Merck & Co., Rahway, New Jersey (S.K., C.L., E.G.R.).; Baeten JM; Gilead Sciences, Foster City, California (F.S., S.-Y.L., S.M., H.D.-S., M.S.R., J.M.B.).; Eron JJ; University of North Carolina at Chapel Hill, Chapel Hill, North Carolina (J.J.E.).

Publisher: American College of Physicians--American Society of Internal Medicine Country of Publication: United States NLM ID: 0372351 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1539-3704 (Electronic) Linking ISSN: 00034819 NLM ISO Abbreviation: Ann Intern Med Subsets: MEDLINE

Cai Y; Gilead Sciences, Inc., Foster City, California, USA.; Podlaha O; Gilead Sciences, Inc., Foster City, California, USA.; Deeks SG; Department of Medicine, University of California San Francisco, San Francisco, California, USA.; Brinson C; Central Texas Clinical Research, Austin, Texas, USA.; Ramgopal MN; Midway Immunology and Research Center, Fort Pierce, Florida, USA.; DeJesus E; Orlando Immunology Centre, Orlando, Florida, USA.; Mills A; Men's Health Foundation, West Hollywood, California, USA.; Shalit P; Peter Shalit MD and Associates, Seattle, Washington, USA.; Abdel-Mohsen M; Vaccine and Immunotherapy Center, The Wistar Institute, Philadelphia, Pennsylvania, USA.; Zhang L; Gilead Sciences, Inc., Foster City, California, USA.; de Vries CR; Gilead Sciences, Inc., Foster City, California, USA.; Vendrame E; Gilead Sciences, Inc., Foster City, California, USA.; SenGupta D; Gilead Sciences, Inc., Foster City, California, USA.; Wallin JJ; Gilead Sciences, Inc., Foster City, California, USA.

Publisher: Wiley-VCH Country of Publication: Germany NLM ID: 1273201 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1521-4141 (Electronic) Linking ISSN: 00142980 NLM ISO Abbreviation: Eur J Immunol Subsets: MEDLINE

Eron JJ; Division of Infectious Diseases, University of North Carolina, Chapel Hill, North Carolina, USA.; Cook PP; Division of Infectious Diseases, East Carolina University, Greenville, North Carolina, USA.; Mehrotra ML; Cinical Research, Gilead Sciences, Inc, Foster City, California, USA.; Huang H; Biostatistics, Gilead Sciences, Inc, Foster City, California, USA.; Caskey M; Laboratory of Molecular Immunology, Rockefeller University, New York, New York, USA.; Crofoot GE; Crofoot MD Clinic and Research Center, Houston, Texas, USA.; Gorgos L; AXCES Research Group, Santa Fe, New Mexico, USA.; VanderVeen LA; Clinical Virology, Gilead Sciences, Inc, Foster City, California, USA.; Zheng Y; Clinical Pharmacology, Gilead Sciences, Inc, Foster City, California, USA.; Collins SE; Clinical Development, Gilead Sciences, Inc, Foster City, California, USA.; Osiyemi OO; Triple O Research Institute PA, West Palm Beach, Florida, USA.; Brinson C; Central Texas Clinical Research, Austin, Texas, USA.; DeJesus E; Orlando Immunology Center, Orlando, Florida, USA.

Publisher: Oxford University Press Country of Publication: United States NLM ID: 0413675 Publication Model: Print Cited Medium: Internet ISSN: 1537-6613 (Electronic) Linking ISSN: 00221899 NLM ISO Abbreviation: J Infect Dis Subsets: MEDLINE

Daar ES; Lundquist Institute at Harbor-UCLA Medical Center, Torrance, CA, USA.; Orkin C; Queen Mary University of London, London, UK.; Sax PE; Brigham and Women's Hospital, Boston, MA, USA.; Hagins D; Coastal CARE Centers, Savannah, GA, USA.; Pozniak A; Chelsea and Westminster Hospital, London, UK.; London School of Hygiene and Tropical Medicine, London, UK.; Workowski K; Emory University, Atlanta, GA, USA.; Brinson C; Central Health, Austin, TX, USA.; Tiraboschi JM; Hospital Universitari de Bellvitge, Barcelona, Spain.; Liu H; Gilead Sciences, Inc., Foster City, CA, USA.; Deaton C; Gilead Sciences, Inc., Foster City, CA, USA.; Cohen C; Gilead Sciences, Inc., Foster City, CA, USA.; Madera S; Gilead Sciences, Inc., Foster City, CA, USA.; Hindman JT; Gilead Sciences, Inc., Foster City, CA, USA. jason.hindman@gilead.com.; Ramgopal M; Midway Research Center and Midway Specialty Care Center, Fort Pierce, FL, USA.

Publisher: BioMed Central Country of Publication: England NLM ID: 101237921 Publication Model: Electronic Cited Medium: Internet ISSN: 1742-6405 (Electronic) Linking ISSN: 17426405 NLM ISO Abbreviation: AIDS Res Ther Subsets: MEDLINE

Kelley CF; Hope Clinic of Emory University School of Medicine, Decatur, GA.; Grady Health System, Atlanta.; Acevedo-Quiñones M; Centro Ararat, San Juan, Puerto Rico.; Agwu AL; Divisions of Pediatric and Adult Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore.; Avihingsanon A; HIV Netherlands Australia Thailand Research Collaboration, Thai Red Cross AIDS Research Centre and Center of Excellence in Tuberculosis, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.; Benson P; Be Well Medical Center, Berkley, MI.; Blumenthal J; Department of Medicine, University of California San Diego, San Diego.; Brinson C; Central Texas Clinical Research, Austin, TX.; Brites C; Complexo Hospitalar Universitário Professor Edgard Santos, Salvador, Brazil.; Cahn P; Fundación Huésped, Buenos Aires.; Cantos VD; Division of Infectious Diseases, Emory University-Ponce de Leon Center Clinical Research Site, HIV/AIDS Clinical Trials Unit, Atlanta.; Clark J; Department of Medicine, University of California, Los Angeles.; Clement M; Department of Infectious Diseases, Louisiana State University Health Sciences Center-New Orleans, New Orleans.; Creticos C; Howard Brown Health, Chicago.; Crofoot G; Crofoot MD Clinic and Research Center, Houston.; Diaz RS; Universidade Federal de São Paulo, São Paulo.; Doblecki-Lewis S; Division of Infectious Diseases, University of Miami Miller School of Medicine, Miami.; Gallardo-Cartagena JA; Centro de Investigaciones Tecnológicas, Biomédicas y Medioambientales, Universidad Nacional Mayor de San Marcos, Lima, Peru.; Gaur A; Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, TN.; Grinsztejn B; Fundação Oswaldo Cruz-Instituto Nacional de Infectologia Evandro Chagas, Rio de Janeiro.; Hassler S; Optimus Medical Group/StudyOps, San Francisco.; Hinojosa JC; Asociación Civil Selva Amazónica, Iquitos, Peru.; Hodge T; Washington Health Institute, Washington, DC.; Kaplan R; Desmond Tutu Health Foundation, Cape Town, South Africa.; Lacerda M; Fundação de Medicina Tropical Doutor Heitor Vieira Dourado, Manaus, Brazil.; LaMarca A; Therafirst Medical Center, Fort Lauderdale, FL.; Losso MH; Hospital General de Agudos José María Ramos Mejía, Buenos Aires.; Valdez Madruga J; Centro de Referência e Treinamento DST/AIDS-SP, São Paulo.; Mayer KH; Fenway Health Medical Clinic, Boston.; Mills A; Mills Clinical Research, West Hollywood, CA.; Mounzer K; Philadelphia FIGHT Community Health Centers-Jonathan Lax Treatment Center, Philadelphia.; Ndlovu N; Wits Reproductive Health and HIV Institute, Faculty of Health Sciences, School of Public Health, University of the Witwatersrand, Johannesburg.; Novak RM; Division of Infectious Diseases, University of Illinois Health Sciences, Chicago.; Perez Rios A; Centro de Investigacion Farmaceutica Especializada de Occidente, Guadalajara, Mexico.; Phanuphak N; Institute of HIV Research and Innovation-Pribta Tangerine Clinic, Bangkok, Thailand.; Ramgopal M; Midway Immunology and Research Center, Fort Pierce, FL.; Ruane PJ; Ruane Clinical Research, Los Angeles.; Sánchez J; Centro de Investigaciones Tecnológicas, Biomédicas y Medioambientales, Universidad Nacional Mayor de San Marcos, Lima, Peru.; Santos B; Infectious Diseases Service, Hospital Nossa Senhora da Conceição, Porto Alegre, Brazil.; Schine P; Bios Clinical Research, Palm Springs, CA.; Schreibman T; CAN Community Health, Sarasota, FL.; Spencer LY; Drew Center for AIDS Research, Education, and Services, Charles R. Drew University, Los Angeles.; Van Gerwen OT; Department of Medicine, Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham.; Vasconcelos R; Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo.; Vasquez JG; Via Libre, Lima, Peru.; Zwane Z; Aurum Institute-Pretoria Clinical Research Site, Pretoria, South Africa.; Cox S; Gilead Sciences, Foster City, CA.; Deaton C; Gilead Sciences, Cambridge, United Kingdom.; Ebrahimi R; Gilead Sciences, Foster City, CA.; Wong P; Gilead Sciences, Foster City, CA.; Singh R; Gilead Sciences, Foster City, CA.; Brown LB; Gilead Sciences, Foster City, CA.; Carter CC; Gilead Sciences, Foster City, CA.; Das M; Gilead Sciences, Foster City, CA.; Baeten JM; Gilead Sciences, Foster City, CA.; Ogbuagu O; Section of Infectious Diseases, Yale School of Medicine, New Haven, CT.

Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1533-4406 (Electronic) Linking ISSN: 00284793 NLM ISO Abbreviation: N Engl J Med Subsets: MEDLINE

Brar I; Henry Ford Hospital, Detroit, MI.; Ruane PJ; Ruane Clinical Research Group, Los Angeles, CA.; Berhe M; North Texas Infectious Diseases Consultants, Dallas, TX.; Brinson C; Central Texas Clinical Research, Austin, TX.; Benson P; Be Well Medical Center, Berkley, MI.; Henry K; Hennepin Healthcare, Minneapolis, MN.; Liu H; Gilead Sciences, Inc., Foster City, CA.; Andreatta K; Gilead Sciences, Inc., Foster City, CA.; Hindman JT; Gilead Sciences, Inc., Foster City, CA.; Ramgopal M; Midway Research Center, Fort Pierce, FL.

Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 2985248R Publication Model: Print Cited Medium: Internet ISSN: 1536-5964 (Electronic) Linking ISSN: 00257974 NLM ISO Abbreviation: Medicine (Baltimore) Subsets: MEDLINE

Riddler SA; Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.; Benson CA; Department of Medicine, UC San Diego, San Diego, CA, USA.; Brinson C; Central Texas Clinical Research, Austin, TX, USA.; Deeks SG; Department of Medicine, University of California San Francisco, San Francisco, CA, USA.; DeJesus E; Orlando Immunology Center, Orlando, FL, USA.; Mills A; Men's Health Foundation, Los Angeles, CA, USA.; Para MF; The Ohio State University Wexner Medical Center, Columbus, OH, USA.; Ramgopal MN; Midway Specialty Care Center, Fort Pierce, FL, USA.; Cai Y; Gilead Sciences, Inc., Foster City, CA, USA.; Zheng Y; Gilead Sciences, Inc., Foster City, CA, USA.; Zhang L; Gilead Sciences, Inc., Foster City, CA, USA.; Jiang W; Gilead Sciences, Inc., Foster City, CA, USA.; Liu X; Gilead Sciences, Inc., Foster City, CA, USA.; Verrill D; Gilead Sciences, Inc., Foster City, CA, USA.; Lim D; Gilead Sciences, Inc., Foster City, CA, USA.; de Vries CR; Gilead Sciences, Inc., Foster City, CA, USA.; Wallin JJ; Gilead Sciences, Inc., Foster City, CA, USA.; Vendrame E; Gilead Sciences, Inc., Foster City, CA, USA.; SenGupta D; Gilead Sciences, Inc., Foster City, CA, USA. devi.sengupta@gilead.com.

Publisher: Adis Country of Publication: New Zealand NLM ID: 101634499 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2193-8229 (Print) Linking ISSN: 21936382 NLM ISO Abbreviation: Infect Dis Ther Subsets: PubMed not MEDLINE

Wohl DA; Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.; Spinner CD; TUM School of Medicine and Health, Department of Clinical Medicine - Clinical Department for Internal Medicine II, University Medical Centre, Technical University of Munich, Munich, Germany.; Flamm J; Kaiser Permanente, Sacramento, CA, USA.; Hare CB; Kaiser Permanente, San Francisco, CA, USA.; Doblecki-Lewis S; Division of Infectious Diseases, University of Miami, Miller School of Medicine, Miami, FL, USA.; Ruane PJ; Ruane Clinical Research, Los Angeles, CA, USA.; Molina JM; Infectious Diseases Department, Hopitaux Saint-Louis Lariboisière, University of Paris and INSERM U944, Paris, France.; Mills A; Men's Health Foundation, Los Angeles, CA, USA.; Brinson C; Central Texas Clinical Research, Austin, TX, USA.; Ramgopal M; Midway Research Center, Fort Pierce, FL, USA.; Clarke A; Royal Sussex County Hospital, University Hospitals Sussex NHS Foundation Trust, Brighton, UK.; Crofoot G; The Crofoot Research Centre, Houston, TX, USA.; Martorell C; The Research Institute, Springfield, MA, USA.; Carter C; Gilead Sciences, Foster City, CA, USA. Electronic address: christoph.carter7@gilead.com.; Cox S; Gilead Sciences, Foster City, CA, USA.; Hojilla JC; Gilead Sciences, Foster City, CA, USA.; Shao Y; Gilead Sciences, Foster City, CA, USA.; Das M; Gilead Sciences, Foster City, CA, USA.; Kintu A; Gilead Sciences, Foster City, CA, USA.; Baeten JM; Gilead Sciences, Foster City, CA, USA.; Grant RM; University of California San Francisco, San Francisco, CA, USA; San Francisco AIDS Foundation, San Francisco, CA, USA.; Mounzer K; Philadelphia FIGHT Community Health Centres, Philadelphia, PA, USA.; Mayer K; The Fenway Institute, Fenway Health, Boston, MA, USA; Department of Medicine, Beth Israel Deaconess Medical Centre/Harvard Medical School, Boston, MA, USA.

Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101645355 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2352-3018 (Electronic) Linking ISSN: 23523018 NLM ISO Abbreviation: Lancet HIV Subsets: MEDLINE

Gupta A; Albion Finch Medical, William Osler Health Centre, Toronto, Ontario, Canada.; Gonzalez-Rojas Y; Optimus U Corp, Miami, Florida.; Juarez E; Florida International Medical Research, Miami.; Crespo Casal M; Álvaro Cunqueiro Hospital, IIS Galicia Sur, Vigo, Pontevedra, Spain.; Moya J; Pines Care Research Center, Pembroke Pines, Florida.; Rodrigues Falci D; Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil.; Sarkis E; Sarkis Clinical Trials, Gainesville, Florida.; Solis J; Centex Studies, McAllen, Texas.; Zheng H; Vir Biotechnology Inc, San Francisco, California.; Scott N; GlaxoSmithKline, Brentford, England.; Cathcart AL; Vir Biotechnology Inc, San Francisco, California.; Parra S; Vir Biotechnology Inc, San Francisco, California.; Sager JE; Vir Biotechnology Inc, San Francisco, California.; Austin D; GlaxoSmithKline, Brentford, England.; Peppercorn A; GlaxoSmithKline, Cambridge, Massachusetts.; Alexander E; Vir Biotechnology Inc, San Francisco, California.; Yeh WW; Vir Biotechnology Inc, San Francisco, California.; Brinson C; Central Texas Clinical Research, Austin.; Aldinger M; Vir Biotechnology Inc, San Francisco, California.; Shapiro AE; Departments of Global Health and Medicine, University of Washington, Seattle.; Fred Hutchinson Cancer Research Center, Seattle, Washington.

Publisher: American Medical Association Country of Publication: United States NLM ID: 7501160 Publication Model: Print Cited Medium: Internet ISSN: 1538-3598 (Electronic) Linking ISSN: 00987484 NLM ISO Abbreviation: JAMA Subsets: MEDLINE

SenGupta D; Gilead Sciences Inc., Foster City, CA, USA.; Brinson C; Central Texas Clinical Research, Austin, TX, USA.; DeJesus E; Orlando Immunology Center, Orlando, FL, USA.; Mills A; Men's Health Foundation, West Hollywood, CA, USA.; Shalit P; Peter Shalit MD and Associates, Seattle, WA, USA.; Guo S; Gilead Sciences Inc., Foster City, CA, USA.; Cai Y; Gilead Sciences Inc., Foster City, CA, USA.; Wallin JJ; Gilead Sciences Inc., Foster City, CA, USA.; Zhang L; Gilead Sciences Inc., Foster City, CA, USA.; Humeniuk R; Gilead Sciences Inc., Foster City, CA, USA.; Begley R; Gilead Sciences Inc., Foster City, CA, USA.; Geleziunas R; Gilead Sciences Inc., Foster City, CA, USA.; Mellors J; University of Pittsburgh, Pittsburg, PA, USA.; Wrin T; Monogram Biosciences, South San Francisco, CA, USA.; Jones N; University of California San Francisco, San Francisco, CA, USA.; Milush J; University of California San Francisco, San Francisco, CA, USA.; Ferre AL; University of California Davis, Davis, CA, USA.; Shacklett BL; University of California Davis, Davis, CA, USA.; Laird GM; Accelevir Diagnostics, Baltimore, MD, USA.; Moldt B; Gilead Sciences Inc., Foster City, CA, USA.; Vendrame E; Gilead Sciences Inc., Foster City, CA, USA.; Brainard DM; Gilead Sciences Inc., Foster City, CA, USA.; Ramgopal M; Midway Specialty Care Center, Fort Pierce, FL, USA.; Deeks SG; University of California San Francisco, San Francisco, CA, USA. steven.deeks@ucsf.edu.

Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101505086 Publication Model: Print Cited Medium: Internet ISSN: 1946-6242 (Electronic) Linking ISSN: 19466234 NLM ISO Abbreviation: Sci Transl Med Subsets: MEDLINE

Riddler SA; Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.; Para M; Wexner Medical Center, The Ohio State University, Columbus, Ohio, USA.; Benson CA; Department of Medicine, University of California San Diego, San Diego, California, USA.; Mills A; SoCal Men's Medical Group, Los Angeles, California, USA.; Ramgopal M; Midway Specialty Care Center, Fort Pierce, Florida, USA.; DeJesus E; Orlando Immunology Center, Orlando, Florida, USA.; Brinson C; Central Texas Clinical Research, Austin, Texas, USA.; Cyktor J; Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.; Jacobs J; Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.; Koontz D; Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.; Mellors JW; Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.; Laird GM; Accelevir Diagnostics, Baltimore, Maryland, USA.; Wrin T; Monogram Biosciences, South San Francisco, California, USA.; Patel H; Gilead Sciences Inc., Foster City, California, USA.; Guo S; Gilead Sciences Inc., Foster City, California, USA.; Wallin J; Gilead Sciences Inc., Foster City, California, USA.; Boice J; Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.; Zhang L; Gilead Sciences Inc., Foster City, California, USA.; Humeniuk R; Gilead Sciences Inc., Foster City, California, USA.; Begley R; Gilead Sciences Inc., Foster City, California, USA.; German P; Gilead Sciences Inc., Foster City, California, USA.; Graham H; Gilead Sciences Inc., Foster City, California, USA.; Geleziunas R; Gilead Sciences Inc., Foster City, California, USA.; Brainard DM; Gilead Sciences Inc., Foster City, California, USA.; SenGupta D; Gilead Sciences Inc., Foster City, California, USA.

Publisher: Oxford University Press Country of Publication: United States NLM ID: 9203213 Publication Model: Print Cited Medium: Internet ISSN: 1537-6591 (Electronic) Linking ISSN: 10584838 NLM ISO Abbreviation: Clin Infect Dis Subsets: MEDLINE

Wang R; ViiV Healthcare, Durham, North Carolina, USA.; Underwood M; ViiV Healthcare, Durham, North Carolina, USA.; Llibre JM; Infectious Diseases Division and Fight Infections Foundation, Hospital Universitari Germans Trias i Pujol, Barcelona, Spain.; Bernal Morell E; Department of Infectious Diseases, Hospital General Universitario Reina Sofía, Murcia, Spain.; Brinson C; Central Texas Clinical Research, Austin, Texas, USA.; Sanz Moreno J; Departamento de Medicina Interna, Hospital Universitario Príncipe de Asturias, Alcalá de Henares, Spain.; Scholten S; Praxis Hohenstaufenring, Cologne, Germany.; Moore R; Northside Clinic, Fitzroy North, Australia.; Saggu P; GSK, Brentford, United Kingdom.; Oyee J; GSK, Brentford, United Kingdom.; Moodley R; ViiV Healthcare, Brentford, United Kingdom.; Wynne B; ViiV Healthcare, Durham, North Carolina, USA.; Kisare M; ViiV Healthcare, Brentford, United Kingdom.; Jones B; ViiV Healthcare, Brentford, United Kingdom.; Ait-Khaled M; ViiV Healthcare, Brentford, United Kingdom.

Publisher: Published by Oxford University Press on behalf of the Infectious Diseases Society of America Country of Publication: United States NLM ID: 101637045 Publication Model: eCollection Cited Medium: Print ISSN: 2328-8957 (Print) Linking ISSN: 23288957 NLM ISO Abbreviation: Open Forum Infect Dis Subsets: PubMed not MEDLINE

Cohn JA; Gagnon S; Spence MR; Harrison DD; Kluzak TR; Langenberg P; Brinson C; Stein A; Hellinger J; American Foundation for AIDS Research Community Based Clinical Trials Network. Cervical Disease Study Group (CORPORATE AUTHOR); Cohn, J A; Gagnon, S; Spence, M R; Harrison, D D; Kluzak, T R; Langenberg, P; Brinson, C; Stein, A; Hellinger, J; Cervical Disease Study Group of the American Foundation for AIDS Research Community Based Clinical Trials Network (CORPORATE AUTHOR)

American Journal of Obstetrics & Gynecology. Feb2001, Vol. 184 Issue 3, p322-330. 9p.

Ogbuagu O; Yale University School of Medicine, New Haven, CT, USA. Electronic address: onyema.ogbuagu@yale.edu.; Segal-Maurer S; New York Presbyterian-Queens, Flushing, NY, USA.; Ratanasuwan W; Siriraj Hospital, Mahidol University, Bangkok, Thailand.; Avihingsanon A; HIV-NAT, Thai Red Cross AIDS Research Centre and Center of Excellence in Tuberculosis, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.; Brinson C; Central Texas Clinical Research, Austin, TX, USA.; Workowski K; Department of Medicine, Emory University, Atlanta, GA, USA.; Antinori A; National Institute for Infectious Diseases Lazzaro Spallanzani, IRCCS, Roma, Italy.; Yazdanpanah Y; Paris Diderot University, Paris, France.; Trottier B; Clinique de Medecine Urbaine du Quartier Latin, Montréal, Québec, Canada.; Wang H; Gilead Sciences, Foster City, CA, USA.; Margot N; Gilead Sciences, Foster City, CA, USA.; Dvory-Sobol H; Gilead Sciences, Foster City, CA, USA.; Rhee MS; Gilead Sciences, Foster City, CA, USA.; Baeten JM; Gilead Sciences, Foster City, CA, USA.; Molina JM; Université de Paris Cité, Paris, France; Département de Maladies Infectieuses, Hôpitaux Saint-Louis, Lariboisière, Assistance Publique Hôpitaux de Paris, Paris, France; INSERM UMR 944, Paris, France.

Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101645355 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2352-3018 (Electronic) Linking ISSN: 23523018 NLM ISO Abbreviation: Lancet HIV Subsets: MEDLINE

Isa F; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA. Electronic address: flonza.isa@regeneron.com.; Forleo-Neto E; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA. Electronic address: eduardo.forleoneto@regeneron.com.; Meyer J; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.; Zheng W; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.; Rasmussen S; Celerion, Lincoln, NE, USA.; Armas D; Celerion, Tempe, AZ, USA.; Oshita M; Benchmark Research, Sacramento, CA, USA.; Brinson C; Central Texas Clinical Research, LLC, Austin, TX, USA.; Folkerth S; Midwest Clinical Research Center, LLC, Dayton, OH, USA.; Faria L; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.; Heirman I; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.; Sarkar N; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.; Musser BJ; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.; Bansal S; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.; O'Brien MP; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.; Turner KC; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.; Ganguly S; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.; Mahmood A; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.; Dupljak A; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.; Hooper AT; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.; Hamilton JD; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.; Kim Y; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.; Kowal B; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.; Soo Y; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.; Geba GP; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.; Lipsich L; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.; Braunstein N; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.; Yancopoulos GD; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.; Weinreich DM; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.; Herman GA; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.

Publisher: Elsevier Country of Publication: Canada NLM ID: 9610933 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-3511 (Electronic) Linking ISSN: 12019712 NLM ISO Abbreviation: Int J Infect Dis Subsets: MEDLINE

Hagins D; Georgia Department of Public Health, Chatham Care Center, Savannah, GA, USA.; Orkin C; Grahame Hayton Unit, Royal London Hospital and Queen Mary University, London, UK.; Daar ES; Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA, USA.; Mills A; Mills Clinical Research, Los Angeles, CA, USA.; Brinson C; Central Texas Clinical Research, Austin, TX, USA.; DeJesus E; Orlando Immunology Center, Orlando, FL, USA.; Post FA; King's College Hospital, London, UK.; Morales-Ramirez J; Clinical Research Puerto Rico Inc., San Juan, Puerto Rico.; Thompson M; AIDS Research Consortium of Atlanta, Atlanta, GA, USA.; Osiyemi O; Triple O Research Institute PA, West Palm Beach, FL, USA.; Rashbaum B; Capital Medical Associates, Washington, DC, USA.; Stellbrink HJ; ICH Study Center, Hamburg, Germany.; Martorell C; The Research Institute, Springfield, MA, USA.; Liu H; Gilead Sciences Inc, Foster City, CA, USA.; Liu YP; Gilead Sciences Inc, Foster City, CA, USA.; Porter D; Gilead Sciences Inc, Foster City, CA, USA.; Collins SE; Gilead Sciences Inc, Foster City, CA, USA.; SenGupta D; Gilead Sciences Inc, Foster City, CA, USA.; Das M; Gilead Sciences Inc, Foster City, CA, USA.

Publisher: Wiley Country of Publication: England NLM ID: 100897392 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-1293 (Electronic) Linking ISSN: 14642662 NLM ISO Abbreviation: HIV Med Subsets: MEDLINE

Kerrigan D; Department of Health, Behavior & Society, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, United States of America.; Mantsios A; Department of Health, Behavior & Society, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, United States of America.; Gorgolas M; Hospital Fundación Jiménez Díaz, Madrid, Spain.; Montes ML; Hospital La Paz, Madrid, Spain.; Pulido F; Hospital Universitario Doce de Octubre, i+12, Madrid, Spain.; Brinson C; Central Texas Clinical Research Corporation, Austin, Texas, United States of America.; deVente J; Living Hope Foundation, Long Beach, California, United States of America.; Richmond GJ; Independent Researcher, Fort Lauderdale, Florida, United States of America.; Beckham SW; Department of Health, Behavior & Society, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, United States of America.; Hammond P; Department of Health, Behavior & Society, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, United States of America.; Margolis D; ViiV Healthcare, Raleigh-Durham, North Carolina, United States of America.; Murray M; ViiV Healthcare, London, United Kingdom.

Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE

Mills A; Men's Health Foundation, Los Angeles, California.; Richmond GJ; Broward Health Medical Center, Fort Lauderdale, Florida.; Newman C; Augusta University Medical Center, Augusta, Georgia.; Osiyemi O; Triple O Research Institute PA, West Palm Beach, Florida.; Cade J; Wellness Center UMC of Southern Nevada, Las Vegas, Nevada.; Brinson C; Central Texas Clinical Research, Austin, Texas.; De Vente J; Long Beach Education and Research Consultants, Long Beach, California.; Margolis DA; Brii Biosciences, Durham.; ViiV Healthcare, Research Triangle Park, North Carolina.; Sutton KC; ViiV Healthcare, Research Triangle Park, North Carolina.; Wilches V; GlaxoSmithKline, Upper Providence, Pennsylvania, USA.; Hatch S; GlaxoSmithKline, Upper Providence, Pennsylvania, USA.; Roberts J; GlaxoSmithKline, Mississauga, Ontario, Canada.; McCoig C; ViiV Healthcare, Tres Cantos, Spain.; Garris C; ViiV Healthcare, Research Triangle Park, North Carolina.; Vandermeulen K; Janssen Research & Development, Beerse, Belgium.; Spreen WR; ViiV Healthcare, Research Triangle Park, North Carolina.

Publisher: Lippincott Williams & Wilkins Country of Publication: England NLM ID: 8710219 Publication Model: Print Cited Medium: Internet ISSN: 1473-5571 (Electronic) Linking ISSN: 02699370 NLM ISO Abbreviation: AIDS Subsets: MEDLINE

Gupta A; From the Albion Finch Medical Centre, William Osler Health Centre, Toronto (A.G.); Optimus U (Y.G.-R.) and Florida International Medical Research (E.J.), Miami, Pines Care Research Center, Pembroke Pines (J.M.), and Sarkis Clinical Trials, Gainesville (E.S.) - all in Florida; Álvaro Cunqueiro Hospital, IIS Galicia Sur, Vigo, Spain (M.C.C.); Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil (D.R.F.); Centex Studies, McAllen (J. Solis), and Central Texas Clinical Research, Austin (C.B.) - both in Texas; Vir Biotechnology, San Francisco (H.Z., A.L.C., C.M.H., J. Sager, E.M., E.A., P.S.P., M.A.); GlaxoSmithKline, Stevenage, United Kingdom (N.S., C.T.); GlaxoSmithKline, Cambridge, MA (A.P.); Pinnacle Research Group, Anniston, AL (A.F.); and the Departments of Global Health and Medicine, University of Washington, and Fred Hutchinson Cancer Research Center, Seattle (A.E.S.).; Gonzalez-Rojas Y; From the Albion Finch Medical Centre, William Osler Health Centre, Toronto (A.G.); Optimus U (Y.G.-R.) and Florida International Medical Research (E.J.), Miami, Pines Care Research Center, Pembroke Pines (J.M.), and Sarkis Clinical Trials, Gainesville (E.S.) - all in Florida; Álvaro Cunqueiro Hospital, IIS Galicia Sur, Vigo, Spain (M.C.C.); Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil (D.R.F.); Centex Studies, McAllen (J. Solis), and Central Texas Clinical Research, Austin (C.B.) - both in Texas; Vir Biotechnology, San Francisco (H.Z., A.L.C., C.M.H., J. Sager, E.M., E.A., P.S.P., M.A.); GlaxoSmithKline, Stevenage, United Kingdom (N.S., C.T.); GlaxoSmithKline, Cambridge, MA (A.P.); Pinnacle Research Group, Anniston, AL (A.F.); and the Departments of Global Health and Medicine, University of Washington, and Fred Hutchinson Cancer Research Center, Seattle (A.E.S.).; Juarez E; From the Albion Finch Medical Centre, William Osler Health Centre, Toronto (A.G.); Optimus U (Y.G.-R.) and Florida International Medical Research (E.J.), Miami, Pines Care Research Center, Pembroke Pines (J.M.), and Sarkis Clinical Trials, Gainesville (E.S.) - all in Florida; Álvaro Cunqueiro Hospital, IIS Galicia Sur, Vigo, Spain (M.C.C.); Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil (D.R.F.); Centex Studies, McAllen (J. Solis), and Central Texas Clinical Research, Austin (C.B.) - both in Texas; Vir Biotechnology, San Francisco (H.Z., A.L.C., C.M.H., J. Sager, E.M., E.A., P.S.P., M.A.); GlaxoSmithKline, Stevenage, United Kingdom (N.S., C.T.); GlaxoSmithKline, Cambridge, MA (A.P.); Pinnacle Research Group, Anniston, AL (A.F.); and the Departments of Global Health and Medicine, University of Washington, and Fred Hutchinson Cancer Research Center, Seattle (A.E.S.).; Crespo Casal M; From the Albion Finch Medical Centre, William Osler Health Centre, Toronto (A.G.); Optimus U (Y.G.-R.) and Florida International Medical Research (E.J.), Miami, Pines Care Research Center, Pembroke Pines (J.M.), and Sarkis Clinical Trials, Gainesville (E.S.) - all in Florida; Álvaro Cunqueiro Hospital, IIS Galicia Sur, Vigo, Spain (M.C.C.); Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil (D.R.F.); Centex Studies, McAllen (J. Solis), and Central Texas Clinical Research, Austin (C.B.) - both in Texas; Vir Biotechnology, San Francisco (H.Z., A.L.C., C.M.H., J. Sager, E.M., E.A., P.S.P., M.A.); GlaxoSmithKline, Stevenage, United Kingdom (N.S., C.T.); GlaxoSmithKline, Cambridge, MA (A.P.); Pinnacle Research Group, Anniston, AL (A.F.); and the Departments of Global Health and Medicine, University of Washington, and Fred Hutchinson Cancer Research Center, Seattle (A.E.S.).; Moya J; From the Albion Finch Medical Centre, William Osler Health Centre, Toronto (A.G.); Optimus U (Y.G.-R.) and Florida International Medical Research (E.J.), Miami, Pines Care Research Center, Pembroke Pines (J.M.), and Sarkis Clinical Trials, Gainesville (E.S.) - all in Florida; Álvaro Cunqueiro Hospital, IIS Galicia Sur, Vigo, Spain (M.C.C.); Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil (D.R.F.); Centex Studies, McAllen (J. Solis), and Central Texas Clinical Research, Austin (C.B.) - both in Texas; Vir Biotechnology, San Francisco (H.Z., A.L.C., C.M.H., J. Sager, E.M., E.A., P.S.P., M.A.); GlaxoSmithKline, Stevenage, United Kingdom (N.S., C.T.); GlaxoSmithKline, Cambridge, MA (A.P.); Pinnacle Research Group, Anniston, AL (A.F.); and the Departments of Global Health and Medicine, University of Washington, and Fred Hutchinson Cancer Research Center, Seattle (A.E.S.).; Falci DR; From the Albion Finch Medical Centre, William Osler Health Centre, Toronto (A.G.); Optimus U (Y.G.-R.) and Florida International Medical Research (E.J.), Miami, Pines Care Research Center, Pembroke Pines (J.M.), and Sarkis Clinical Trials, Gainesville (E.S.) - all in Florida; Álvaro Cunqueiro Hospital, IIS Galicia Sur, Vigo, Spain (M.C.C.); Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil (D.R.F.); Centex Studies, McAllen (J. Solis), and Central Texas Clinical Research, Austin (C.B.) - both in Texas; Vir Biotechnology, San Francisco (H.Z., A.L.C., C.M.H., J. Sager, E.M., E.A., P.S.P., M.A.); GlaxoSmithKline, Stevenage, United Kingdom (N.S., C.T.); GlaxoSmithKline, Cambridge, MA (A.P.); Pinnacle Research Group, Anniston, AL (A.F.); and the Departments of Global Health and Medicine, University of Washington, and Fred Hutchinson Cancer Research Center, Seattle (A.E.S.).; Sarkis E; From the Albion Finch Medical Centre, William Osler Health Centre, Toronto (A.G.); Optimus U (Y.G.-R.) and Florida International Medical Research (E.J.), Miami, Pines Care Research Center, Pembroke Pines (J.M.), and Sarkis Clinical Trials, Gainesville (E.S.) - all in Florida; Álvaro Cunqueiro Hospital, IIS Galicia Sur, Vigo, Spain (M.C.C.); Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil (D.R.F.); Centex Studies, McAllen (J. Solis), and Central Texas Clinical Research, Austin (C.B.) - both in Texas; Vir Biotechnology, San Francisco (H.Z., A.L.C., C.M.H., J. Sager, E.M., E.A., P.S.P., M.A.); GlaxoSmithKline, Stevenage, United Kingdom (N.S., C.T.); GlaxoSmithKline, Cambridge, MA (A.P.); Pinnacle Research Group, Anniston, AL (A.F.); and the Departments of Global Health and Medicine, University of Washington, and Fred Hutchinson Cancer Research Center, Seattle (A.E.S.).; Solis J; From the Albion Finch Medical Centre, William Osler Health Centre, Toronto (A.G.); Optimus U (Y.G.-R.) and Florida International Medical Research (E.J.), Miami, Pines Care Research Center, Pembroke Pines (J.M.), and Sarkis Clinical Trials, Gainesville (E.S.) - all in Florida; Álvaro Cunqueiro Hospital, IIS Galicia Sur, Vigo, Spain (M.C.C.); Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil (D.R.F.); Centex Studies, McAllen (J. Solis), and Central Texas Clinical Research, Austin (C.B.) - both in Texas; Vir Biotechnology, San Francisco (H.Z., A.L.C., C.M.H., J. Sager, E.M., E.A., P.S.P., M.A.); GlaxoSmithKline, Stevenage, United Kingdom (N.S., C.T.); GlaxoSmithKline, Cambridge, MA (A.P.); Pinnacle Research Group, Anniston, AL (A.F.); and the Departments of Global Health and Medicine, University of Washington, and Fred Hutchinson Cancer Research Center, Seattle (A.E.S.).; Zheng H; From the Albion Finch Medical Centre, William Osler Health Centre, Toronto (A.G.); Optimus U (Y.G.-R.) and Florida International Medical Research (E.J.), Miami, Pines Care Research Center, Pembroke Pines (J.M.), and Sarkis Clinical Trials, Gainesville (E.S.) - all in Florida; Álvaro Cunqueiro Hospital, IIS Galicia Sur, Vigo, Spain (M.C.C.); Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil (D.R.F.); Centex Studies, McAllen (J. Solis), and Central Texas Clinical Research, Austin (C.B.) - both in Texas; Vir Biotechnology, San Francisco (H.Z., A.L.C., C.M.H., J. Sager, E.M., E.A., P.S.P., M.A.); GlaxoSmithKline, Stevenage, United Kingdom (N.S., C.T.); GlaxoSmithKline, Cambridge, MA (A.P.); Pinnacle Research Group, Anniston, AL (A.F.); and the Departments of Global Health and Medicine, University of Washington, and Fred Hutchinson Cancer Research Center, Seattle (A.E.S.).; Scott N; From the Albion Finch Medical Centre, William Osler Health Centre, Toronto (A.G.); Optimus U (Y.G.-R.) and Florida International Medical Research (E.J.), Miami, Pines Care Research Center, Pembroke Pines (J.M.), and Sarkis Clinical Trials, Gainesville (E.S.) - all in Florida; Álvaro Cunqueiro Hospital, IIS Galicia Sur, Vigo, Spain (M.C.C.); Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil (D.R.F.); Centex Studies, McAllen (J. Solis), and Central Texas Clinical Research, Austin (C.B.) - both in Texas; Vir Biotechnology, San Francisco (H.Z., A.L.C., C.M.H., J. Sager, E.M., E.A., P.S.P., M.A.); GlaxoSmithKline, Stevenage, United Kingdom (N.S., C.T.); GlaxoSmithKline, Cambridge, MA (A.P.); Pinnacle Research Group, Anniston, AL (A.F.); and the Departments of Global Health and Medicine, University of Washington, and Fred Hutchinson Cancer Research Center, Seattle (A.E.S.).; Cathcart AL; From the Albion Finch Medical Centre, William Osler Health Centre, Toronto (A.G.); Optimus U (Y.G.-R.) and Florida International Medical Research (E.J.), Miami, Pines Care Research Center, Pembroke Pines (J.M.), and Sarkis Clinical Trials, Gainesville (E.S.) - all in Florida; Álvaro Cunqueiro Hospital, IIS Galicia Sur, Vigo, Spain (M.C.C.); Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil (D.R.F.); Centex Studies, McAllen (J. Solis), and Central Texas Clinical Research, Austin (C.B.) - both in Texas; Vir Biotechnology, San Francisco (H.Z., A.L.C., C.M.H., J. Sager, E.M., E.A., P.S.P., M.A.); GlaxoSmithKline, Stevenage, United Kingdom (N.S., C.T.); GlaxoSmithKline, Cambridge, MA (A.P.); Pinnacle Research Group, Anniston, AL (A.F.); and the Departments of Global Health and Medicine, University of Washington, and Fred Hutchinson Cancer Research Center, Seattle (A.E.S.).; Hebner CM; From the Albion Finch Medical Centre, William Osler Health Centre, Toronto (A.G.); Optimus U (Y.G.-R.) and Florida International Medical Research (E.J.), Miami, Pines Care Research Center, Pembroke Pines (J.M.), and Sarkis Clinical Trials, Gainesville (E.S.) - all in Florida; Álvaro Cunqueiro Hospital, IIS Galicia Sur, Vigo, Spain (M.C.C.); Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil (D.R.F.); Centex Studies, McAllen (J. Solis), and Central Texas Clinical Research, Austin (C.B.) - both in Texas; Vir Biotechnology, San Francisco (H.Z., A.L.C., C.M.H., J. Sager, E.M., E.A., P.S.P., M.A.); GlaxoSmithKline, Stevenage, United Kingdom (N.S., C.T.); GlaxoSmithKline, Cambridge, MA (A.P.); Pinnacle Research Group, Anniston, AL (A.F.); and the Departments of Global Health and Medicine, University of Washington, and Fred Hutchinson Cancer Research Center, Seattle (A.E.S.).; Sager J; From the Albion Finch Medical Centre, William Osler Health Centre, Toronto (A.G.); Optimus U (Y.G.-R.) and Florida International Medical Research (E.J.), Miami, Pines Care Research Center, Pembroke Pines (J.M.), and Sarkis Clinical Trials, Gainesville (E.S.) - all in Florida; Álvaro Cunqueiro Hospital, IIS Galicia Sur, Vigo, Spain (M.C.C.); Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil (D.R.F.); Centex Studies, McAllen (J. Solis), and Central Texas Clinical Research, Austin (C.B.) - both in Texas; Vir Biotechnology, San Francisco (H.Z., A.L.C., C.M.H., J. Sager, E.M., E.A., P.S.P., M.A.); GlaxoSmithKline, Stevenage, United Kingdom (N.S., C.T.); GlaxoSmithKline, Cambridge, MA (A.P.); Pinnacle Research Group, Anniston, AL (A.F.); and the Departments of Global Health and Medicine, University of Washington, and Fred Hutchinson Cancer Research Center, Seattle (A.E.S.).; Mogalian E; From the Albion Finch Medical Centre, William Osler Health Centre, Toronto (A.G.); Optimus U (Y.G.-R.) and Florida International Medical Research (E.J.), Miami, Pines Care Research Center, Pembroke Pines (J.M.), and Sarkis Clinical Trials, Gainesville (E.S.) - all in Florida; Álvaro Cunqueiro Hospital, IIS Galicia Sur, Vigo, Spain (M.C.C.); Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil (D.R.F.); Centex Studies, McAllen (J. Solis), and Central Texas Clinical Research, Austin (C.B.) - both in Texas; Vir Biotechnology, San Francisco (H.Z., A.L.C., C.M.H., J. Sager, E.M., E.A., P.S.P., M.A.); GlaxoSmithKline, Stevenage, United Kingdom (N.S., C.T.); GlaxoSmithKline, Cambridge, MA (A.P.); Pinnacle Research Group, Anniston, AL (A.F.); and the Departments of Global Health and Medicine, University of Washington, and Fred Hutchinson Cancer Research Center, Seattle (A.E.S.).; Tipple C; From the Albion Finch Medical Centre, William Osler Health Centre, Toronto (A.G.); Optimus U (Y.G.-R.) and Florida International Medical Research (E.J.), Miami, Pines Care Research Center, Pembroke Pines (J.M.), and Sarkis Clinical Trials, Gainesville (E.S.) - all in Florida; Álvaro Cunqueiro Hospital, IIS Galicia Sur, Vigo, Spain (M.C.C.); Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil (D.R.F.); Centex Studies, McAllen (J. Solis), and Central Texas Clinical Research, Austin (C.B.) - both in Texas; Vir Biotechnology, San Francisco (H.Z., A.L.C., C.M.H., J. Sager, E.M., E.A., P.S.P., M.A.); GlaxoSmithKline, Stevenage, United Kingdom (N.S., C.T.); GlaxoSmithKline, Cambridge, MA (A.P.); Pinnacle Research Group, Anniston, AL (A.F.); and the Departments of Global Health and Medicine, University of Washington, and Fred Hutchinson Cancer Research Center, Seattle (A.E.S.).; Peppercorn A; From the Albion Finch Medical Centre, William Osler Health Centre, Toronto (A.G.); Optimus U (Y.G.-R.) and Florida International Medical Research (E.J.), Miami, Pines Care Research Center, Pembroke Pines (J.M.), and Sarkis Clinical Trials, Gainesville (E.S.) - all in Florida; Álvaro Cunqueiro Hospital, IIS Galicia Sur, Vigo, Spain (M.C.C.); Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil (D.R.F.); Centex Studies, McAllen (J. Solis), and Central Texas Clinical Research, Austin (C.B.) - both in Texas; Vir Biotechnology, San Francisco (H.Z., A.L.C., C.M.H., J. Sager, E.M., E.A., P.S.P., M.A.); GlaxoSmithKline, Stevenage, United Kingdom (N.S., C.T.); GlaxoSmithKline, Cambridge, MA (A.P.); Pinnacle Research Group, Anniston, AL (A.F.); and the Departments of Global Health and Medicine, University of Washington, and Fred Hutchinson Cancer Research Center, Seattle (A.E.S.).; Alexander E; From the Albion Finch Medical Centre, William Osler Health Centre, Toronto (A.G.); Optimus U (Y.G.-R.) and Florida International Medical Research (E.J.), Miami, Pines Care Research Center, Pembroke Pines (J.M.), and Sarkis Clinical Trials, Gainesville (E.S.) - all in Florida; Álvaro Cunqueiro Hospital, IIS Galicia Sur, Vigo, Spain (M.C.C.); Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil (D.R.F.); Centex Studies, McAllen (J. Solis), and Central Texas Clinical Research, Austin (C.B.) - both in Texas; Vir Biotechnology, San Francisco (H.Z., A.L.C., C.M.H., J. Sager, E.M., E.A., P.S.P., M.A.); GlaxoSmithKline, Stevenage, United Kingdom (N.S., C.T.); GlaxoSmithKline, Cambridge, MA (A.P.); Pinnacle Research Group, Anniston, AL (A.F.); and the Departments of Global Health and Medicine, University of Washington, and Fred Hutchinson Cancer Research Center, Seattle (A.E.S.).; Pang PS; From the Albion Finch Medical Centre, William Osler Health Centre, Toronto (A.G.); Optimus U (Y.G.-R.) and Florida International Medical Research (E.J.), Miami, Pines Care Research Center, Pembroke Pines (J.M.), and Sarkis Clinical Trials, Gainesville (E.S.) - all in Florida; Álvaro Cunqueiro Hospital, IIS Galicia Sur, Vigo, Spain (M.C.C.); Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil (D.R.F.); Centex Studies, McAllen (J. Solis), and Central Texas Clinical Research, Austin (C.B.) - both in Texas; Vir Biotechnology, San Francisco (H.Z., A.L.C., C.M.H., J. Sager, E.M., E.A., P.S.P., M.A.); GlaxoSmithKline, Stevenage, United Kingdom (N.S., C.T.); GlaxoSmithKline, Cambridge, MA (A.P.); Pinnacle Research Group, Anniston, AL (A.F.); and the Departments of Global Health and Medicine, University of Washington, and Fred Hutchinson Cancer Research Center, Seattle (A.E.S.).; Free A; From the Albion Finch Medical Centre, William Osler Health Centre, Toronto (A.G.); Optimus U (Y.G.-R.) and Florida International Medical Research (E.J.), Miami, Pines Care Research Center, Pembroke Pines (J.M.), and Sarkis Clinical Trials, Gainesville (E.S.) - all in Florida; Álvaro Cunqueiro Hospital, IIS Galicia Sur, Vigo, Spain (M.C.C.); Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil (D.R.F.); Centex Studies, McAllen (J. Solis), and Central Texas Clinical Research, Austin (C.B.) - both in Texas; Vir Biotechnology, San Francisco (H.Z., A.L.C., C.M.H., J. Sager, E.M., E.A., P.S.P., M.A.); GlaxoSmithKline, Stevenage, United Kingdom (N.S., C.T.); GlaxoSmithKline, Cambridge, MA (A.P.); Pinnacle Research Group, Anniston, AL (A.F.); and the Departments of Global Health and Medicine, University of Washington, and Fred Hutchinson Cancer Research Center, Seattle (A.E.S.).; Brinson C; From the Albion Finch Medical Centre, William Osler Health Centre, Toronto (A.G.); Optimus U (Y.G.-R.) and Florida International Medical Research (E.J.), Miami, Pines Care Research Center, Pembroke Pines (J.M.), and Sarkis Clinical Trials, Gainesville (E.S.) - all in Florida; Álvaro Cunqueiro Hospital, IIS Galicia Sur, Vigo, Spain (M.C.C.); Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil (D.R.F.); Centex Studies, McAllen (J. Solis), and Central Texas Clinical Research, Austin (C.B.) - both in Texas; Vir Biotechnology, San Francisco (H.Z., A.L.C., C.M.H., J. Sager, E.M., E.A., P.S.P., M.A.); GlaxoSmithKline, Stevenage, United Kingdom (N.S., C.T.); GlaxoSmithKline, Cambridge, MA (A.P.); Pinnacle Research Group, Anniston, AL (A.F.); and the Departments of Global Health and Medicine, University of Washington, and Fred Hutchinson Cancer Research Center, Seattle (A.E.S.).; Aldinger M; From the Albion Finch Medical Centre, William Osler Health Centre, Toronto (A.G.); Optimus U (Y.G.-R.) and Florida International Medical Research (E.J.), Miami, Pines Care Research Center, Pembroke Pines (J.M.), and Sarkis Clinical Trials, Gainesville (E.S.) - all in Florida; Álvaro Cunqueiro Hospital, IIS Galicia Sur, Vigo, Spain (M.C.C.); Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil (D.R.F.); Centex Studies, McAllen (J. Solis), and Central Texas Clinical Research, Austin (C.B.) - both in Texas; Vir Biotechnology, San Francisco (H.Z., A.L.C., C.M.H., J. Sager, E.M., E.A., P.S.P., M.A.); GlaxoSmithKline, Stevenage, United Kingdom (N.S., C.T.); GlaxoSmithKline, Cambridge, MA (A.P.); Pinnacle Research Group, Anniston, AL (A.F.); and the Departments of Global Health and Medicine, University of Washington, and Fred Hutchinson Cancer Research Center, Seattle (A.E.S.).; Shapiro AE; From the Albion Finch Medical Centre, William Osler Health Centre, Toronto (A.G.); Optimus U (Y.G.-R.) and Florida International Medical Research (E.J.), Miami, Pines Care Research Center, Pembroke Pines (J.M.), and Sarkis Clinical Trials, Gainesville (E.S.) - all in Florida; Álvaro Cunqueiro Hospital, IIS Galicia Sur, Vigo, Spain (M.C.C.); Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil (D.R.F.); Centex Studies, McAllen (J. Solis), and Central Texas Clinical Research, Austin (C.B.) - both in Texas; Vir Biotechnology, San Francisco (H.Z., A.L.C., C.M.H., J. Sager, E.M., E.A., P.S.P., M.A.); GlaxoSmithKline, Stevenage, United Kingdom (N.S., C.T.); GlaxoSmithKline, Cambridge, MA (A.P.); Pinnacle Research Group, Anniston, AL (A.F.); and the Departments of Global Health and Medicine, University of Washington, and Fred Hutchinson Cancer Research Center, Seattle (A.E.S.).

Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1533-4406 (Electronic) Linking ISSN: 00284793 NLM ISO Abbreviation: N Engl J Med Subsets: MEDLINE

Orkin C; Department of Immunobiology, Queen Mary University, London, UK. Electronic address: c.m.orkin@qmul.ac.uk.; Oka S; AIDS Clinical Center, National Center for Global Health and Medicine, Tokyo, Japan.; Philibert P; Department for Internal Medicine and Infectious Diseases, Hôpital Européen, Marseille, France.; Brinson C; Central Texas Clinical Research, Austin, TX, USA.; Bassa A; Mzansi Ethical Research Centre, Middelburg, South Africa.; Gusev D; State Medical Center for the Prevention and Control of AIDS and Infectious Diseases, St Petersburg, Russia; St Petersburg State Budgetary Health Care Institution, St Petersburg, Russia.; Degen O; Infectious Diseases Unit, Outpatient Center, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.; García JG; Department for Internal Medicine, Hospital La Paz Institute for Health Research, Hospital Universitario La Paz, Madrid, Spain.; Morell EB; Sección de Enfermedades Infecciosas, Hospital General Universitario Reina Sofía, Murcia, Spain.; Tan DHS; Division of Infectious Diseases, Department of Medicine, St Michael's Hospital, Toronto, ON, Canada.; D'Amico R; Research and Development, ViiV Healthcare, Research Triangle Park, NC, USA.; Dorey D; Biostatistics, GlaxoSmithKline, Mississauga, ON, Canada.; Griffith S; Research and Development, ViiV Healthcare, Research Triangle Park, NC, USA.; Thiagarajah S; SMG Pharma Safety, GlaxoSmithKline, Research Triangle Park, NC, USA.; St Clair M; Translational Medical Research, ViiV Healthcare, Research Triangle Park, NC, USA.; Van Solingen-Ristea R; Infectious Diseases & Vaccines, Janssen Research & Development, Beerse, Belgium.; Crauwels H; Infectious Diseases & Vaccines, Janssen Research & Development, Beerse, Belgium.; Ford SL; Clinical Pharmacology, GlaxoSmithKline, Research Triangle Park, NC, USA.; Patel P; Research and Development, ViiV Healthcare, Research Triangle Park, NC, USA.; Chounta V; Health Outcomes Team, ViiV Healthcare, Brentford, UK.; Vanveggel S; Global Development, Janssen Research & Development, Beerse, Belgium.; Cutrell A; Research Statistics, ViiV Healthcare, Research Triangle Park, NC, USA.; Van Eygen V; Infectious Diseases & Vaccines, Janssen Research & Development, Beerse, Belgium.; Vandermeulen K; Infectious Diseases & Vaccines, Janssen Research & Development, Beerse, Belgium.; Margolis DA; Research and Development, ViiV Healthcare, Research Triangle Park, NC, USA.; Smith KY; Research and Development, ViiV Healthcare, Research Triangle Park, NC, USA.; Spreen WR; Research and Development, ViiV Healthcare, Research Triangle Park, NC, USA.

Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101645355 Publication Model: Print Cited Medium: Internet ISSN: 2352-3018 (Electronic) Linking ISSN: 23523018 NLM ISO Abbreviation: Lancet HIV Subsets: MEDLINE